tiprankstipranks
Trending News
More News >
Fate Therapeutics (FATE)
NASDAQ:FATE
US Market

Fate Therapeutics (FATE) Stock Investors

Compare
1,195 Followers
Based on 804,828 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold FATE
On average, investors allocate 2.27% of their portfolios to FATE
The average holding size of this company in investors' portfolios.

Investor Sentiment

Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 804,828 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding FATE

1.1%
Last 7
Days
2.2%
Last 30
Days
Percentages indicate the change in the number of portfolios holding FATE, out of 804,828 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

FATE Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
1.04%
$1.52
Based on the activity of investors who made their portfolios public
The table shows changes in FATE in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

FATE Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
4.30%
-0.75%
+4.54%
36.03B
Consumer Cyclical
JD
4.38%
-0.03%
+0.57%
50.33B
Consumer Cyclical
Block
3.44%
-0.92%
-1.38%
39.11B
Technology
Nio
7.51%
-0.59%
-0.48%
7.08B
Consumer Cyclical
Bristol-Myers Squibb
3.07%
-0.21%
+0.41%
95.36B
Healthcare
Zscaler
3.71%
-0.71%
+7.10%
47.17B
Technology
CVS Health
4.00%
-0.51%
-1.35%
84.21B
Healthcare
Intuitive Surgical
3.24%
-1.16%
+0.44%
182.56B
Healthcare
Riot Platforms
4.55%
+0.05%
-0.23%
3.42B
Financial
Lucid Group
5.15%
+0.96%
+1.32%
6.68B
Consumer Cyclical
Based on the activity of 804,828 active portfolios
Open your Smart Portfolio

FATE Investor Analysis

FATE investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
12.2%
of FATE holders
are under 35
Average Segment Performance
Average P/E Ratio22.53
Beta-2.07
Dividend Yield4.06%
FATE investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
57.0%
of FATE holders
are between 35–55
Average Segment Performance
Average P/E Ratio17.36
Beta3.39
Dividend Yield3.52%
FATE investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
30.8%
of FATE holders
are over 55
Average Segment Performance
Average P/E Ratio15.02
Beta-2.47
Dividend Yield3.69%
Overview of age group and performance of FATE stock investors
See who invests in FATE according to age group and performance.

FAQ

How many retail Investors hold FATE?
<0.1% of TipRanks' retail investors hold FATE in their portfolios.
    What is FATE Investor Sentiment?
    FATE’s Investor Sentiment is Positive.
      What percentage of retail investors changed their holding of FATE in the last 7 days?
      ▼ 1.1% of TipRanks' retail investors changed their holding of FATE in the last 7 days.
        What percentage of retail investors changed their holding of FATE in the last 30 days?
        ▲ 2.2% of TipRanks' retail investors changed their holding of FATE in the last 30 days.
          What is the average age of retail investors who hold FATE?
          The average age of FATE Holders is between 35–55.
            What other stocks have FATE investors also bought?
            FATE Investors also bought DKNG, JD, XYZ, NIO, BMY, ZS, CVS, ISRG, RIOT, LCID.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis